Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Fulgent Genetics, Inc. (FLGT)

Gao Hanlin — Chief Scientific Officer
Jun 2, 2026
Sale
Shares
1,688
Price
$17.89
Total Value
$30.19K
Shares Held After
990,374
% of Holdings
0.2%

Alector, Inc. (ALEC)

Rosenthal Arnon — Director
Jun 2, 2026
Sale
Shares
87,216
Price
$1.97
Total Value
$172.19K
Shares Held After
2,367,206
% of Holdings
3.6%

NovoCure Ltd (NVCR)

HILLEMAN JERYL L — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
13,861
% of Holdings
17.5%

NovoCure Ltd (NVCR)

LEUNG GABRIEL — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
89,499
% of Holdings
3.2%

NovoCure Ltd (NVCR)

VERNON W ANTHONY — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
197,657
% of Holdings
1.5%

NovoCure Ltd (NVCR)

Ocean Allyson J — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
11,324
% of Holdings
20.6%

NovoCure Ltd (NVCR)

Stafford Kristin — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
11,324
% of Holdings
20.6%

Progyny, Inc. (PGNY)

Livingston Mark S. — CHIEF FINANCIAL OFFICER
Jun 2, 2026
Sale
Shares
279
Price
$26.20
Total Value
$7.31K
Shares Held After
78,626
% of Holdings
0.4%

NovoCure Ltd (NVCR)

Hung David — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
20,465
% of Holdings
12.6%

Progyny, Inc. (PGNY)

Clapp Geoffrey — Chief Product Officer
Jun 2, 2026
Sale
Shares
1,530
Price
$25.58
Total Value
$39.14K
Shares Held After
59,117
% of Holdings
2.5%

NovoCure Ltd (NVCR)

Scannell Timothy J — Director
Jun 2, 2026
Sale
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
14,288
% of Holdings
17.1%

Teladoc Health, Inc. (TDOC)

Rodrigues Fernando M. — President of BetterHelp
Jun 2, 2026
Sale
Shares
5,677
Price
$7.63
Total Value
$43.30K
Shares Held After
9,572
% of Holdings
37.2%
Jun 2, 2026
Purchase
Shares
5,000
Price
$4.21
Total Value
$21.04K
Shares Held After
20,000
% of Holdings
25.0%
Jun 2, 2026
Purchase
Shares
5,000
Price
$4.18
Total Value
$20.90K
Shares Held After
15,000
% of Holdings
33.3%

Liquidia Corp (LQDA)

KIRSCH ARTHUR S — Director
Jun 2, 2026
Sale
Shares
5,000
Price
$56.00
Total Value
$280.00K
Shares Held After
10,000
% of Holdings
33.3%
Jun 2, 2026
Sale
Shares
1,757,955
Price
$0.11
Total Value
$188.10K
Shares Held After
0
% of Holdings
100.0%
Jun 2, 2026
Purchase
Shares
50,000
Price
$9.43
Total Value
$471.30K
Shares Held After
886,000
% of Holdings
5.6%

MCKESSON CORP (MCK)

Rodgers Thomas L — EVP, Chief Strategy & BDO
Jun 2, 2026
Sale
Shares
699
Price
$735.27
Total Value
$513.95K
Shares Held After
2,268
% of Holdings
23.6%
Jun 2, 2026
Purchase
Shares
206,005
Price
$15.28
Total Value
$3.15M
Shares Held After
13,044,106
% of Holdings
1.6%
Jun 2, 2026
Sale
Shares
349
Price
$4.46
Total Value
$1.56K
Shares Held After
181,509
% of Holdings
0.2%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Jun 2, 2026
Sale
Shares
8,148
Price
$16.60
Total Value
$135.25K
Shares Held After
13,579
% of Holdings
37.5%
Jun 2, 2026
Sale
Shares
5,537
Price
$223.39
Total Value
$1.24M
Shares Held After
29,603
% of Holdings
15.8%

Alignment Healthcare, Inc. (ALHC)

Kent Mark D. — President - MSO
Jun 2, 2026
Purchase
Shares
14,848
Price
$13.31
Total Value
$197.63K
Shares Held After
14,848
% of Holdings
100.0%

HYPERION DEFI, INC. (HYPD)

Jung Hyunsu — Director
Jun 2, 2026
Purchase
Shares
500
Price
$3.68
Total Value
$1.84K
Shares Held After
1,385,676
% of Holdings
0.0%

HYPERION DEFI, INC. (HYPD)

Jung Hyunsu — Director
Jun 2, 2026
Purchase
Shares
500
Price
$3.64
Total Value
$1.82K
Shares Held After
1,385,176
% of Holdings
0.0%

Marpai, Inc. (MRAI)

Johnson Steve Andrew — Chief Financial Officer
Jun 2, 2026
Purchase
Shares
1,100
Price
$0.62
Total Value
$682.00
Shares Held After
1,024,192
% of Holdings
0.1%

Ascendis Pharma A/S (ASND)

SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Jun 2, 2026
Purchase
Shares
100
Price
$219.00
Total Value
$21.90K
Shares Held After
4,367
% of Holdings
2.3%
Jun 1, 2026
Sale
Shares
3,294
Price
$71.38
Total Value
$235.13K
Shares Held After
597,540
% of Holdings
0.5%
Jun 1, 2026
Sale
Shares
8,149
Price
$70.50
Total Value
$574.50K
Shares Held After
600,834
% of Holdings
1.3%
Jun 1, 2026
Sale
Shares
3,557
Price
$69.40
Total Value
$246.86K
Shares Held After
608,983
% of Holdings
0.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jun 1, 2026
Sale
Shares
572
Price
$220.67
Total Value
$126.22K
Shares Held After
137,643
% of Holdings
0.4%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jun 1, 2026
Sale
Shares
213
Price
$219.34
Total Value
$46.72K
Shares Held After
138,215
% of Holdings
0.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jun 1, 2026
Sale
Shares
413
Price
$218.84
Total Value
$90.38K
Shares Held After
138,428
% of Holdings
0.3%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jun 1, 2026
Sale
Shares
1,802
Price
$217.52
Total Value
$391.97K
Shares Held After
138,841
% of Holdings
1.3%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Jun 1, 2026
Sale
Shares
3,100
Price
$72.06
Total Value
$223.39K
Shares Held After
97,994
% of Holdings
3.1%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Jun 1, 2026
Sale
Shares
2,599
Price
$70.77
Total Value
$183.93K
Shares Held After
101,094
% of Holdings
2.5%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Jun 1, 2026
Sale
Shares
1,801
Price
$69.75
Total Value
$125.62K
Shares Held After
103,693
% of Holdings
1.7%
Jun 1, 2026
Sale
Shares
5,401
Price
$68.35
Total Value
$369.14K
Shares Held After
767,780
% of Holdings
0.7%
Jun 1, 2026
Sale
Shares
12,989
Price
$67.41
Total Value
$875.59K
Shares Held After
773,181
% of Holdings
1.7%
Jun 1, 2026
Sale
Shares
1,610
Price
$66.39
Total Value
$106.88K
Shares Held After
786,170
% of Holdings
0.2%

Replimune Group, Inc. (REPL)

Sarchi Christopher — Chief Commercial Officer
Jun 1, 2026
Sale
Shares
12,000
Price
$9.24
Total Value
$110.88K
Shares Held After
180,962
% of Holdings
6.2%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
Jun 1, 2026
Sale
Shares
828
Price
$439.91
Total Value
$364.25K
Shares Held After
19,959
% of Holdings
4.0%
Jun 1, 2026
Sale
Shares
235
Price
$279.13
Total Value
$65.60K
Shares Held After
0
% of Holdings
100.0%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Jun 1, 2026
Sale
Shares
3,931
Price
$70.75
Total Value
$278.10K
Shares Held After
8,977
% of Holdings
30.5%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Jun 1, 2026
Sale
Shares
21,069
Price
$70.11
Total Value
$1.48M
Shares Held After
12,908
% of Holdings
62.0%

CORCEPT THERAPEUTICS INC (CORT)

Mokari Atabak — Chief Financial Officer
Jun 1, 2026
Sale
Shares
40,000
Price
$70.00
Total Value
$2.80M
Shares Held After
15,257
% of Holdings
72.4%

Septerna, Inc. (SEPN)

Shaikhly Samira — Chief People Officer
Jun 1, 2026
Sale
Shares
2,889
Price
$29.66
Total Value
$85.70K
Shares Held After
793
% of Holdings
78.5%

Septerna, Inc. (SEPN)

Shaikhly Samira — Chief People Officer
Jun 1, 2026
Sale
Shares
1,346
Price
$28.79
Total Value
$38.76K
Shares Held After
3,682
% of Holdings
26.8%

Septerna, Inc. (SEPN)

Shaikhly Samira — Chief People Officer
Jun 1, 2026
Sale
Shares
1,700
Price
$27.78
Total Value
$47.23K
Shares Held After
5,028
% of Holdings
25.3%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Jun 1, 2026
Sale
Shares
2,254
Price
$1.54
Total Value
$3.47K
Shares Held After
457,711
% of Holdings
0.5%
Version: v26.5.2